MO Expands Smoke-Free Portfolio: Can It Offset Combustible Declines?

Altria Group (MO) demonstrated progress in its smoke-free transition during Q2 2025, with 'on!' oral nicotine pouch shipments surging 26.5% and driving a 10.9% increase in oral tobacco operating income at 68.7% margins. This growth partially mitigated a 10.2% decline in domestic cigarette volumes, underscoring the ongoing challenge of offsetting combustible product erosion. While 'on!' is central to Altria's strategy, the long-term effectiveness of this offset remains uncertain given intensifying competition in the smoke-free market. MO shares have recently outperformed the industry, trading at an attractive 11.4x forward P/E with slightly upward revised EPS estimates.

Analysis

Altria Group (MO) is demonstrating a critical strategic pivot toward smoke-free products, with its oral nicotine pouch brand, on!, serving as the primary growth engine. In the second quarter of 2025, on! shipments surged 26.5% year-over-year, elevating its share of the oral tobacco category to 8.7% and driving a 10.9% increase in the segment's adjusted operating income with robust margins of 68.7%. This progress, however, is juxtaposed with a significant structural headwind from its legacy business, where domestic cigarette shipments fell 10.2%. While the company's recent stock performance has outpaced the industry with a 3.8% gain over the past month, the central question for investors remains whether the growth in its smoke-free portfolio can adequately offset the erosion of its combustible segment. The competitive environment is intensifying, with Philip Morris International reporting 17.3% organic growth in its smoke-free division and a 26% surge in ZYN offtake, while Turning Point Brands is rapidly scaling its own pouch offerings. Despite these pressures, Altria trades at a discounted forward P/E of 11.4x compared to the industry average of 14.9x, and analyst consensus EPS estimates for 2025 and 2026 have seen a modest increase, suggesting a cautiously optimistic outlook on its transition.

Key Decisions for Investors

• Investors should evaluate Altria's performance based on the net effect of its high-margin smoke-free growth against the persistent volume declines in its core combustible business.
• The stock's discounted forward P/E of 11.4x relative to the industry average could represent a value opportunity, contingent on the 'on!' brand's ability to continue scaling and capturing market share.
• It is critical to monitor the competitive performance of Philip Morris's ZYN and Turning Point Brands' white pouches, as their growth directly impacts Altria's potential to dominate the expanding oral nicotine category.
• Given the recent 3.8% share price outperformance against a declining industry, investors may consider holding positions while watching for signs that smoke-free operating income growth can accelerate to fully bridge the gap left by falling cigarette sales.